1.17
                                            Schlusskurs vom Vortag:
              $1.20
            Offen:
              $1.19
            24-Stunden-Volumen:
                53,039
            Relative Volume:
              0.04
            Marktkapitalisierung:
                $12.03M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              -
            KGV:
              -
            EPS:
                -
            Netto-Cashflow:
                -
            1W Leistung:
              -15.83%
            1M Leistung:
              -15.22%
            6M Leistung:
                -43.48%
            1J Leistung:
              +0.00%
            Gelteq Ltd Stock (GELS) Company Profile
Vergleichen Sie GELS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
|   
                          
                                GELS
                            
                             Gelteq Ltd | 1.17 | 12.03M | 0 | 0 | 0 | 0.00 | 
|   
                          
                                ZTS
                            
                             Zoetis Inc | 144.10 | 63.79B | 9.39B | 2.62B | 2.22B | 5.8121 | 
|   
                          
                                TAK
                            
                             Takeda Pharmaceutical Co Adr | 13.23 | 43.49B | 29.96B | 957.25M | 4.77B | 0.2956 | 
|   
                          
                                HLN
                            
                             Haleon Plc Adr | 9.18 | 40.30B | 14.26B | 1.98B | 2.47B | 0.4327 | 
|   
                          
                                TEVA
                            
                             Teva Pharmaceutical Industries Ltd Adr | 20.03 | 23.21B | 16.70B | -157.13M | 1.19B | -0.1446 | 
|   
                          
                                UTHR
                            
                             United Therapeutics Corp | 453.53 | 20.59B | 3.08B | 1.24B | 1.07B | 25.61 | 
Gelteq Ltd Aktie (GELS) Neueste Nachrichten
Will Gelteq Limited stock continue dividend increases2025 Risk Factors & Low Risk High Reward Ideas - newser.com
Key metrics from Gelteq Limited’s quarterly dataQuarterly Profit Summary & AI Enhanced Trade Execution Alerts - newser.com
How moving averages guide Gelteq Limited tradingAnalyst Upgrade & Proven Capital Preservation Tips - newser.com
What margin trends mean for Gelteq Limited stockWeekly Gains Report & Smart Swing Trading Techniques - newser.com
Will Gelteq Limited stock reach all time highs in 2025July 2025 Final Week & Weekly Setup with High ROI Potential - newser.com
Gelteq Announces Commencement of Preclinical Trial Targeting Oil Soluble Drug Market with Novel Delivery Platform - MSN
Will Gelteq Limited stock continue upward momentumTrade Entry Report & Low Risk Investment Opportunities - Fundação Cultural do Pará
Is Gelteq Limited stock supported by strong fundamentals2025 Technical Overview & Growth Focused Stock Reports - newser.com
Is Gelteq Limited stock near bottom after decline2025 Analyst Calls & Weekly Top Gainers Alerts - newser.com
Market reaction to Gelteq Limited’s recent newsOil Prices & Real-Time Stock Entry Alerts - newser.com
What technical models suggest about Gelteq Limited’s comebackEarnings Trend Report & Real-Time Market Sentiment Alerts - newser.com
Real time pattern detection on Gelteq Limited stockTrade Risk Summary & Daily Technical Forecast Reports - newser.com
Is Gelteq Limited stock dividend yield sustainableWeekly Stock Summary & Capital Efficient Trading Techniques - newser.com
Gelteq (GELS) starts preclinical trial with Monash for oily, poorly soluble drugs - Stock Titan
Using portfolio simulators with Gelteq Limited includedWeekly Volume Report & Smart Money Movement Alerts - newser.com
Published on: 2025-10-21 21:31:20 - newser.com
Investment Review: How Gelteq Limited stock performs in interest rate cycles2025 Investor Takeaways & Community Shared Stock Ideas - Trung tâm Dự báo KTTV quốc gia
What analyst consensus says on Gelteq Limited stock2025 Retail Activity & Low Drawdown Momentum Ideas - Trung tâm Dự báo KTTV quốc gia
Is Gelteq Limited stock a buy on dips2025 Technical Patterns & Free Expert Verified Stock Movement Alerts - Trung tâm Dự báo KTTV quốc gia
How Gelteq Limited stock performs in interest rate cyclesLong Setup & AI Powered Market Entry Strategies - Trung tâm Dự báo KTTV quốc gia
Published on: 2025-10-18 12:21:43 - Trung tâm Dự báo KTTV quốc gia
Can Gelteq Limited stock sustain institutional interest2025 Historical Comparison & Expert Curated Trade Setups - Trung tâm Dự báo KTTV quốc gia
Is Gelteq Limited stock ready for a breakout2025 Institutional Moves & Fast Momentum Stock Entry Tips - newser.com
Gelteq Limited (GELS) Stock Price, News, Quote & History - Yahoo
Gelteq Limited (GELS) Latest Press Releases & Corporate News - Yahoo
Gelteq partners with Melbourne Health to develop bowel cancer prevention gel - Investing.com India
Gelteq Announces New Product Development Agreement with Melbourne Health for Novel Bowel Polyp Growth Reduction Compound - The Manila Times
HAMSB product development: Gelteq and Melbourne Health partner to target bowel polyp growth reduction - Stock Titan
What moving averages say about Gelteq LimitedJuly 2025 Pullbacks & Safe Capital Growth Stock Tips - newser.com
Using Python tools to backtest Gelteq Limited strategiesMarket Movers & Long-Term Growth Plans - newser.com
Does Gelteq Limited fit your quant trading modelQuarterly Portfolio Summary & Daily Oversold Stock Bounce Ideas - newser.com
Will Gelteq Limited stock deliver better than expected guidance2025 Stock Rankings & Daily Chart Pattern Signals - newser.com
Can Gelteq Limited hit a new high this monthGold Moves & Free Safe Entry Trade Signal Reports - newser.com
Risk vs reward if holding onto Gelteq LimitedQuarterly Portfolio Report & Weekly Watchlist for Hot Stocks - newser.com
Finanzdaten der Gelteq Ltd-Aktie (GELS)
        Es liegen keine Finanzdaten für Gelteq Ltd (GELS) vor. Überprüfen Sie andere Aktien für weitere Informationen.
    
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):
                 
            
         
                     
                             Holen Sie sich die Stockscreener-App
                    Holen Sie sich die Stockscreener-App